TERMINATION OF LICENSE AGREEMENTTermination of License Agreement • March 7th, 2024 • Fresh Tracks Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 7th, 2024 Company IndustryThis Termination of License Agreement (this “Agreement”) is made and entered into as of March 1, 2024 by and between Carna Biosciences, Inc., a corporation organized under the laws of Japan (“Carna”) and Fresh Tracks Therapeutics, Inc. (f/k/a Brickell Biotech, Inc.), a Delaware corporation (“FRTX”).